NFV, an HIV-1 protease inhibitor, induces growth arrest, reduced Akt signalling, apoptosis and docetaxel sensitisation in NSCLC cell lines. [electronic resource]
- British journal of cancer Dec 2006
- 1653-62 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
0007-0920
10.1038/sj.bjc.6603435 doi
Adenocarcinoma--drug therapy Animals Antineoplastic Agents--therapeutic use Apoptosis--drug effects Carcinoma, Large Cell--drug therapy Carcinoma, Non-Small-Cell Lung--drug therapy Carcinoma, Squamous Cell--drug therapy Cell Line, Tumor Cell Proliferation--drug effects Cyclin-Dependent Kinase Inhibitor p21--metabolism Cyclin-Dependent Kinase Inhibitor p27 Docetaxel Down-Regulation Drug Combinations Glycogen Synthase Kinases--metabolism HIV Protease Inhibitors--pharmacology Humans Intracellular Signaling Peptides and Proteins--metabolism Lung Neoplasms--drug therapy Male Mice Mice, Inbred BALB C Mice, Nude Nelfinavir--pharmacology Proto-Oncogene Proteins c-akt--antagonists & inhibitors Proto-Oncogene Proteins c-bcl-2--metabolism RNA, Small Interfering--pharmacology Signal Transduction--drug effects Taxoids--therapeutic use Tumor Suppressor Protein p53--metabolism